Abstract
The pathophysiology of endotoxic shock is complex. This review emphasizes the role of reactive oxygen species (ROS) in the pathophysiology of endotoxic shock and the effectiveness of flaxseed in amelioration of the deleterious effects of endotoxic shock on the cardiovascular function and health of the tissue. Endotoxic shock is associated with reduction in the cardiac function measured by cardiac index and left ventricular work index, cardiac contractility measured by dp/dt (rate of change of left ventricular pressure development), dp/dt at CPIP/PAW, where CPIP is common peak isovolumetric pressure and PAW is pulmonary arterial wedge pressure, arterial pressure, and cellular damage measured by increased plasma creatine kinase and elavated plasma lactate. It is also accompanied by increases in the generation of ROS by polymorphonuclear leukocytes, and cardiac lipid peroxidation product malondialdehyde (MDA) (cardiac MDA) and reduction in antioxidant reserve and antioxidant enzyme activity. Dimethylthiourea an antioxidant, prevented/reduced the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, ROS generated by polymorphonuclear leucocytes; MDA, antioxidant reserve and antioxidant enzyme activity of cardiac tissue, and cellular health. Flaxseed which has antioxidant component ameliorated the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, oxidative stress parameters and cellular health. In conclusion, the data suggest that ROS may play a role in the pathophysiology of endotoxic shock and that flaxseed, an antioxidant may have a role in the treatment of endotoxic shock.
Keywords: Flaxseed, reactive oxygen species, antioxidant, dimethylthiourea, endotoxic shock, cardiac function, cardiac contractility, arterial pressure, antioxidant reserve, antioxidant enzymes, creatine kinase, lactate.
Current Pharmaceutical Design
Title:Flaxseed and Endotoxic Shock
Volume: 20 Issue: 9
Author(s): Kailash Prasad
Affiliation:
Keywords: Flaxseed, reactive oxygen species, antioxidant, dimethylthiourea, endotoxic shock, cardiac function, cardiac contractility, arterial pressure, antioxidant reserve, antioxidant enzymes, creatine kinase, lactate.
Abstract: The pathophysiology of endotoxic shock is complex. This review emphasizes the role of reactive oxygen species (ROS) in the pathophysiology of endotoxic shock and the effectiveness of flaxseed in amelioration of the deleterious effects of endotoxic shock on the cardiovascular function and health of the tissue. Endotoxic shock is associated with reduction in the cardiac function measured by cardiac index and left ventricular work index, cardiac contractility measured by dp/dt (rate of change of left ventricular pressure development), dp/dt at CPIP/PAW, where CPIP is common peak isovolumetric pressure and PAW is pulmonary arterial wedge pressure, arterial pressure, and cellular damage measured by increased plasma creatine kinase and elavated plasma lactate. It is also accompanied by increases in the generation of ROS by polymorphonuclear leukocytes, and cardiac lipid peroxidation product malondialdehyde (MDA) (cardiac MDA) and reduction in antioxidant reserve and antioxidant enzyme activity. Dimethylthiourea an antioxidant, prevented/reduced the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, ROS generated by polymorphonuclear leucocytes; MDA, antioxidant reserve and antioxidant enzyme activity of cardiac tissue, and cellular health. Flaxseed which has antioxidant component ameliorated the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, oxidative stress parameters and cellular health. In conclusion, the data suggest that ROS may play a role in the pathophysiology of endotoxic shock and that flaxseed, an antioxidant may have a role in the treatment of endotoxic shock.
Export Options
About this article
Cite this article as:
Prasad Kailash, Flaxseed and Endotoxic Shock, Current Pharmaceutical Design 2014; 20 (9) . https://dx.doi.org/10.2174/13816128113199990557
DOI https://dx.doi.org/10.2174/13816128113199990557 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
Current Cardiology Reviews Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Biological Imaging and Spectroscopy of pH
Current Organic Chemistry Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications
Current Diabetes Reviews A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications
Current Diabetes Reviews Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Current Diabetes Reviews Hypertension in Peripheral Arterial Disease
Current Pharmaceutical Design Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
Current Cardiology Reviews The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology The ACE2-Ang-(1-7)-Mas Axis and Cardioprotection
Current Cardiology Reviews Human Use of Leucoselect® Phytosome® with Special Reference to Inflammatory- Allergic Pathologies in Frail Elderly Patients
Current Pharmaceutical Design Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Current Medicinal Chemistry - Central Nervous System Agents Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases
Current Drug Targets Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets Occurrence and Clinical Impact of Microembolic Signals (MES) in Patients with Chronic Cardiac Diseases and Atheroaortic Plaques - A Systematic Review
Current Vascular Pharmacology Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia
Current Vascular Pharmacology Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease
Current Vascular Pharmacology Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts
Current Pharmaceutical Biotechnology Drugs in Newborn Resuscitation: The More We Learn the Least We Use
Current Medicinal Chemistry